Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487357 · ClinicalTrials.gov registry record
MATCh Parents' Supplemental Survey
A clinical trial of Epidemiology, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 1,215
- Enrollment target
- 1
- Study location
NCT00487357: Completed study of Epidemiology, sponsored by M.D. Anderson Cancer Center.
NCT00487357 is a study of Epidemiology that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,215 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00487357, a study of Epidemiology, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 1,215 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objectives: 1. To collect data on health behaviors in the parents of MATCh study participants 2. To collect and/or update risk factor data from the parents of the MATCh study participants.
Conditions Studied
Interventions
- BEHAVIORAL Supplemental Survey
Study Locations (1)
Texas
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,215 participants |
| Start Date | 2006-06 |
| Est. Completion | 2012-05 |
What the finished NCT00487357 record still lists
NCT00487357 is an observational study that tracks outcomes without assigning an intervention. Its 1,215 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Epidemiology appearing as the primary indexed condition, and to 1 intervention - of which Supplemental Survey is the first listed.
NCT00487357 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00487357 about?
NCT00487357 is a clinical study titled "MATCh Parents' Supplemental Survey". Primary Objectives: 1. To collect data on health behaviors in the parents of MATCh study participants 2. To collect and/or update risk factor data from the parents of the MATCh study participants.
What is the current status of trial NCT00487357?
This trial is currently completed. The enrollment target is 1,215 participants. The study started on 2006-06. Estimated completion is 2012-05.
What conditions does trial NCT00487357 study?
This clinical trial studies the following conditions: Epidemiology.
What interventions are being tested in trial NCT00487357?
The interventions under investigation include: Supplemental Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT00487357?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00487357 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epidemiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05827016 · 1,216 participants · Phase 3
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
- NCT06143956 · 1,217 participants · Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia